3-23-2022: Although the full dose of Actemra (tocilizumab) would be more reliable, giving everybody a half dose might save more lives: https://t.co/OHgGrMXCRZ https://t.co/rTVk54eWVx https://t.co/I8yzQSwgv7 https://t.co/rek0JN2UiB https://t.co/CLztloNlaZ
3-29-2021: The 10-27-2020 pro-Actemra clinical trial by Russell M. Petrak of Burr Ridge, Illinois, has now been peer reviewed. 81 patients were given Actemra, while 37 patients were given the fake Actemra: https://t.co/rTVk54eWVx https://t.co/a7xr19AxBV
11-18-2020: Rewrite of the 7-20-2020 LOW-DOSE Actemra (tocilizumab) clinical trial from Chicago with 32 Actemra patients vs. 41 controls https://t.co/OHgGrMXCRZ https://t.co/CLztloNlaZ https://t.co/rek0JN2UiB https://t.co/I8yzQSwgv7 https://t.co/rTVk54eWVx
5-13-2020: More good news from Italy for 62 patients given LOW-DOSE Actemra (tocilizumab) versus 23 controls: https://t.co/rTVk54eWVx https://t.co/2xRXcDuAc6 https://t.co/2oi57ODgaP https://t.co/CLztloNlaZ https://t.co/rek0JN2UiB https://t.co/I8yzQSwgv7 h
10-8-2020: In a study just released today from Spain, good news for the PREEMPTIVE use of full-dose Actemra (tocilizumab) for treating early COVID-19: https://t.co/rTVk54eWVx https://t.co/rek0JN2UiB https://t.co/I8yzQSwgv7 https://t.co/tSlcnUZl9f https://
7-17-2020: Surprisingly good news from Italy for EARLY USE of LOW DOSE Actemra (tocilizumab) for COVID-19. 50% death versus 7.7% death rate. Confirms the good results for low dose Actemra from Illinois: https://t.co/rTVk54eWVx https://t.co/I8yzQSwgv7 ht
8-20-2020: The people of India have not been fooled by Genentech's negatively spun trial result for Actemra (tocilizumab): https://t.co/9FeSM87wJs https://t.co/m5fZ4NaPj1 https://t.co/d5daO97XoG https://t.co/rTVk54eWVx https://t.co/HYhKCAPwEJ https://t.co
8-20-2020: India's Cipla has been cut off by Roche/Chugai, forcing Indian pharmacists to decide who gets the tocilizumab and who doesn't https://t.co/W1yDQZH96W https://t.co/d5daO97XoG https://t.co/m5fZ4NaPj1 https://t.co/EAZBjw4DBc https://t.co/HYhKCAPwEJ
RT @rmchavin: 8-11-2020: The Indian Medical Association says how Actemra (tocilizumab) is injected makes a huge difference on how effectiv…
8-16-2020: Genentech's negatively spun trial results for Actemra (tocilizumab) hasn't fooled the people of India https://t.co/f0nBALA3Pz https://t.co/d5daO97XoG https://t.co/m5fZ4NaPj1 https://t.co/rTVk54eWVx https://t.co/KJM4rX9Zi9 https://t.co/HYhKCAPwEJ
8-12-2020: Good news from Santiago, Chile for Actemra (tocilizumab) for treating mid-stage & end-stage COVID-19 https://t.co/EAZBjw4DBc https://t.co/m5fZ4NaPj1 https://t.co/d5daO97XoG https://t.co/HYhKCAPwEJ https://t.co/tUKxmkaeH7 https://t.co/KJM4rX
RT @rmchavin: 8-11-2020: The Indian Medical Association says how Actemra (tocilizumab) is injected makes a huge difference on how effectiv…
RT @rmchavin: 8-11-2020: The Indian Medical Association says how Actemra (tocilizumab) is injected makes a huge difference on how effectiv…
8-11-2020: The Indian Medical Association says how Actemra (tocilizumab) is injected makes a huge difference on how effective & how expensive it will be. Why? https://t.co/w0TWjoxqE6 https://t.co/d5daO97XoG https://t.co/m5fZ4NaPj1 https://t.co/rTVk54
7-9-2020: Health Minister Nitin Patel says the Gujarat government has given away for free, 2,080 (93.7%) out of the 2,220 injections of Actemra (tocilizumab) that they purchased at Rs45,000 each from Cipla: https://t.co/aYiLSfRh0E https://t.co/RuA6vbvQKY
8-4-2020: Although Actemra (tocilizumab) has not been approved by the evil American FDA for COVID-19, it has been approved in the U.S. for many other diseases: https://t.co/WgFkntb6z4 https://t.co/joEX4g3Y2f https://t.co/rTVk54eWVx https://t.co/PUPl4nBysa
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 https://t.co/a4OVV279SI
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @garthstrohbehn: And it's out. https://t.co/G26UlLmCdP
RT @UCHemOncFellows: Preprint of the COVIDOSE trial featuring numerous @UCHemOncFellows fellows and @UCCancerCenter faculty
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
7-28-2020: Another easy victory for the champion, Actemra (tocilizumab), but this time, in a different sport (not COVID-19), and only among very young children https://t.co/7VhEkNPhQx https://t.co/7CHFis1J2q https://t.co/HYhKCAPwEJ https://t.co/rTVk54eWVx
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
#Covid19 #Preprint "COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19" by Garth W. Strohbehn MD, MPhil, Brian L. Heiss, MD, Sherin J. Rouhani, MD, PhD, Jonathan A. Trujillo, MD, PhD, et al, July 26, 2020: https://t.co/1xY7cqZ13F
RT @garthstrohbehn: And it's out. https://t.co/G26UlLmCdP
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @outbreaksci: New #SARSCoV preprint: COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 https://t.co/TsHQ2hUQTr
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
New #SARSCoV preprint: COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 https://t.co/TsHQ2hUQTr
Contribute a rapid review or request one for "COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19" (https://t.co/TsHQ2hUQTr). "Add" or "Request" w/DOI (10.1101/2020.07.20.20157503) at https://t.co/RnurTL3DyM @outbreaksci @PREreview_
New #COVID19 preprint: COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 https://t.co/TsHQ2hUQTr
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @garthstrohbehn: And it's out. https://t.co/G26UlLmCdP
RT @UCHemOncFellows: Preprint of the COVIDOSE trial featuring numerous @UCHemOncFellows fellows and @UCCancerCenter faculty https://t.co/hF…
Garth’s quarantine project (understatement of the century) is live!
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
𝗧𝗶𝘁𝗹𝗲: COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19. 𝗔𝘂𝘁𝗵𝗼𝗿𝘀: Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, Jonathan A Trujillo, Jovian Yu, Alec J Kacew, Emily F Higgs, Jeffrey C Bloodworth, Alexandr... https://t.co/18oo6oEmn4 https://
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
RT @ABsteward: The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose…
The dose of Tocilizumab is a mystery,4/8mg or 800mg /400mg or lower, one or more doses, 24h/48h.Maybe we just need low dose Hopefully COVACTA /#Recoverytrial will give us some clues It's disappointing WHO #solidarity trial didn't provide any clue for the t
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 https://t.co/WXHjvDkqwc プレプリント 低用量アクテムラ
7-20-2020: In a scientific study just released today from the University of Chicago, extremely good news for LOW-DOSE Actemra (tocilizumab) for treating mid-stage & end-stage COVID-19, confirming the sanity of the desperate behavior by the people of I
The paper “COVIDOSE: Low-dose tocilizumab in the treatment of...” (https://t.co/UUuBKv7lTv) has been reviewed by a set of automated tools; find the results of the analysis here: https://t.co/3Gc0MCCia0. We detected 2 of 5 rigor criteria and 16 key resource
@leochacon @Irerodsa
RT @Covid19Crusher: Proof-of-concept study shows low doses of tocilizumab (1/10 of usual) might do the trick. Good news given its expensive…
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @zenutopia1: Covidose Le #tocilizumab à faible dose a été associé à une amélioration rapide des mesures cliniques et de laboratoire de l…
@drakchaurasia @Dharmen46587056 @__ice9 @ishan_bhupendra
@SumiSukanya @Teensthack @rdivia @AskDrShashank @ICMRDELHI @ProfBhargava
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
RT @ABsteward: 🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective co…
🔥Preprint🔥 COVIDOSE study @garthstrohbehn : A small phase 2 trial of low-dose tocilizumab "40 to 200 mg" Vs retrospective control to assess the relationship of dose to fever resolution and CRP response in non vents pts with #COVID19 https://t.co/2n9XlDpJo
Preprint of the COVIDOSE trial featuring numerous @UCHemOncFellows fellows and @UCCancerCenter faculty
And it's out. https://t.co/G26UlLmCdP
RT @medrxivpreprint: COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 https://t.co/Rh6Wh271fU #medRxiv
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 https://t.co/Rh6Wh271fU #medRxiv